clopidogrel bioequivalence - PD endpoint [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2007-05-30 14:47 (6966 d 08:44 ago) – Posting: # 760
Views: 10,530

Dear Kshitij!

❝ i meant any submission (and approval) of clopidogrel formulation based upon a study using PD end points. So, is the submission, which you are referring to, based on PD endpoints?


No… :-D

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
195 visitors (0 registered, 195 guests [including 83 identified bots]).
Forum time: 23:32 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5